Publications
14 publications
Clinical research
4 studies
Active
2 studies- PIPrevalence of headache as a chief complaint in pediatric patients with brain tumors: a retrospective chart reviewWeill Medical College of Cornell University · OPEN TO ACCRUAL (as of 2025)
- PINCT04649242Phase 3, Multicenter, Randomized, Double-blind, Group Sequential, Placebo-controlled Study to Assess Efficacy and Safety of Rimegepant for the Treatment of Migraine (With or Without Aura) in Children and Adolescents ≥ 6 to < 18 Years of AgePHASE3 · Pfizer, Inc. · OPEN TO ACCRUAL (as of 2024)Pediatric Migraine
Completed & closed trials (2)
- PINCT05008874Prospective, Retrospective, Multicenter, Observational Study of Disease Progression in Adults With Inherited Forms of Spastic ParaplegiaSwanBio Therapeutics Limited · IRB STUDY CLOSURE (as of 2025)AMN; AMN Gene Mutation; X-ALD
- PINCT04998396A Phase 1/2 Open-Label Study of the Safety and Clinical Activity of Gene Therapy for Canavan Disease Through Administration of an Adeno-Associated Virus (AAV) Serotype 9-Based Recombinant Vector Encoding the Human ASPA GenePHASE1; PHASE2 · Aspa Therapeutics, Inc. · IRB STUDY CLOSURE (as of 2024)Canavan Disease